ArticleOncology letters2021

PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma.

Hiroaki Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.